Participant global assessment: satisfaction with treatment Questionnaire · participants with hidradenitis suppurativa
Intense pulsed light may leads to higher participant global assessment: satisfaction with treatment… compared with no treatment (low certainty).
1 finding from 1 review
Participant global assessment: satisfaction with treatment ‐ axilla Questionnaire · participants with hidradenitis suppurativa
Intense pulsed light may leads to higher participant global assessment: satisfaction with treatment ‐ axilla… compared with no treatment (low certainty).
1 finding from 1 review
Participant global assessment: satisfaction with treatment ‐ groin Questionnaire · participants with hidradenitis suppurativa
Intense pulsed light showed no clear difference in participant global assessment: satisfaction with treatment ‐ groin… compared with no treatment (low certainty).
1 finding from 1 review
RR 5 [0.31, 79.94]
1 study · 8 participants
Low
Participant global assessment: satisfaction with treatment ‐ inframammary Questionnaire · participants with hidradenitis suppurativa
Intense pulsed light showed no clear difference in participant global assessment: satisfaction with treatment ‐… compared with no treatment (low certainty).
1 finding from 1 review
RR 3 [0.24, 37.67]
1 study · 2 participants
Low
HRQOL ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Participant‐assessed improvement in rosacea severity · Participants with rosacea
1 finding from 1 review
Proportion of participants with adverse event Pain as · Participants with rosacea
1 finding from 1 review
Physician‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Assessment of erythema or telangiectasia · Participants with rosacea
1 finding from 1 review
Lesion count ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Time needed until improvement ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Duration of remission ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Dry eye symptoms, measured using the OSDI score (ranging from 0 to 100 units, with a reduction in scores indicating clinical improvement) at 1‐month (with actual · people with meibomian gland dysfunction
It is very uncertain whether IPL (with/without MGX) changes dry eye symptoms, measured using the SPEED score at 3 months of compared with sham or no treatment (with/without MGX) (very low certainty).
1 finding from 1 review
MD 0
Studies not reported
Very low
Incidence of adverse events at 3 months of · people with meibomian gland dysfunction
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Clinical signs—TBUT at 1 month (seconds) · people with meibomian gland dysfunction
IPL (with/without MGX) showed no clear difference in sodium fluorescein TBUT, measured in seconds, at 3 months of compared with sham or no treatment (with/without MGX) (low certainty).
1 finding from 1 review
MD 2.02
Studies not reported
Low
NIBUT, measured in seconds, at 3 months of · people with meibomian gland dysfunction
It is very uncertain whether IPL (with/without MGX) changes NIBUT, measured in seconds, at 3 months of compared with sham or no treatment (with/without MGX) (very low certainty).
1 finding from 1 review
MD 5.5
Studies not reported
Very low
Tear osmolarity, measured in mOsmol/L, at 3 months of · people with meibomian gland dysfunction
IPL (with/without MGX) showed no clear difference in tear osmolarity, measured in mOsmol/L, at 3 months of compared with sham or no treatment (with/without MGX) (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Meibomian gland orifice plugging, at 3 months of · people with meibomian gland dysfunction
It is very uncertain whether IPL (with/without MGX) changes meibomian gland orifice plugging, at 3 months of compared with sham or no treatment (with/without MGX) (very low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Corneal sodium fluorescein staining, measured using a validated clinical scale, at 3 months of · people with meibomian gland dysfunction
It is very uncertain whether IPL (with/without MGX) changes corneal sodium fluorescein staining, measured using a validated… compared with sham or no treatment (with/without MGX) (very low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Very low